You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Older Adults May Need B12 Dose More Than 200 Times the RDA to Normalize Mild Vitamin Deficiency

  • Authors: News Author: Laurie Barclay, MD
    CME Author: Charles Vega, MD, FAAFP
  • CME Released: 5/27/2005; Reviewed and Renewed: 5/26/2006
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 5/26/2007, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This article is intended for primary care physicians, geriatricians, endocrinologists, and other specialists who care for patients with vitamin B12 deficiency.

The goal of this activity is to provide the latest medical news to physicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  • Describe the clinical presentation of B12 deficiency and its treatment.
  • Specify the minimum effective dose of oral vitamin B12 necessary to treat mild deficiency in older adults.


Disclosures

As an organization accredited by the ACCME, Medscape requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as "financial relationships in any amount, occurring within the past 12 months," that could create a conflict of interest.

Medscape encourages Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Laurie Barclay, MD

    Laurie Barclay is a freelance reviewer and writer for Medscape.

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Reviewer(s)

  • Gary Vogin, MD

    Senior Medical Editor, Medscape

    Disclosures

    Disclosure: Gary Vogin, MD, has disclosed no relevant financial relationships.

CME Author(s)

  • Charles P Vega, MD

    Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine

    Disclosures

    Disclosure: Charles Vega, MD, FAAFP, has disclosed that he has received grants for educational activities from Pfizer.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape designates this educational activity for 0.25 category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that reflect the time he/she actually spent in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Older Adults May Need B12 Dose More Than 200 Times the RDA to Normalize Mild Vitamin Deficiency

Authors: News Author: Laurie Barclay, MD CME Author: Charles Vega, MD, FAAFPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 5/27/2005; Reviewed and Renewed: 5/26/2006

Valid for credit through: 5/26/2007, 11:59 PM EST

processing....

May 27, 2005 -- In adults older than age 70 years, a dose more than 200 times the recommended dietary allowance (RDA) of B 12 is necessary to normalize mild deficiency, according to the results of a randomized study published in the May 23 issue of the Archives of Internal Medicine.

"Supplementation with high doses of oral cobalamin is as effective as cobalamin administered by intramuscular injection to correct plasma markers of vitamin B 12 deficiency, but the effects of lower oral doses of cobalamin on such markers are uncertain," write Simone J.P.M. Eussen, MSc, from Wageningen University in the Netherlands, and colleagues.

In this parallel-group, double-blind, dose-finding trial, the investigators assessed the effects of daily oral doses of 2.5, 100, 250, 500, and 1,000 µg of cyanocobalamin administered for 16 weeks on biochemical markers of vitamin B 12 deficiency in 120 older people. Study subjects had mild vitamin B 12 deficiency, defined as a serum vitamin B 12 level of 100 to 300 pmol/L (135 - 406 pg/mL) and a methylmalonic acid level of at least 0.26 µmol/L. The primary outcome was the dose of oral cyanocobalamin that produced 80% to 90% of the estimated maximal reduction in the plasma methylmalonic acid concentration.

Supplementation with cyanocobalamin at daily oral doses of 2.5, 100, 250, 500, and 1,000 µg was associated with mean reductions in plasma methylmalonic acid concentrations of 16%, 16%, 23%, 33%, and 33%, respectively. To achieve 80% to 90% of the estimated maximum reduction in the plasma methylmalonic acid concentration, daily doses of 647 to 1,032 µg of cyanocobalamin were required.

Study limitations include the variable absorption of vitamin B 12 in older people, current assay techniques that may misclassify a significant proportion of individuals with vitamin B 12 deficiency, lack of consensus about the cutoff points for vitamin B 12 deficiency or metabolites to define vitamin B 12 deficiency, and the extent to which differences in individual responses were due to active vs passive absorption of vitamin B 12.

"The lowest dose of oral cyanocobalamin required to normalize mild vitamin B 12 deficiency is more than 200 times greater than the recommended dietary allowance, which is approximately 3 µg daily," the authors write. "Clinical trials are currently assessing the effects of high doses of oral cobalamin on markers of cognitive function and depression. If such trials can demonstrate that the reported associations of vitamin B 12 deficiency with cognitive impairment or depression are causal and reversible by treatment, the relevance of correction of vitamin B 12 deficiency in older people could be substantial."

ZonMw in the Hague, Kellogg's Benelux, the Foundation to Promote Research Into Functional Vitamin B 12 Deficiency, and the European Union BIOMED Demonstration Project supported this study.

The authors report no financial disclosures.

Arch Intern Med. 2005;165:1167-1172